CLPT
ClearPoint Neuro Inc

3,277
Mkt Cap
$373.94M
Volume
4.04M
52W High
$30.10
52W Low
$9.05
PE Ratio
-11.86
CLPT Fundamentals
Price
$9.80
Prev Close
$12.57
Open
$9.91
50D MA
$14.03
Beta
2.02
Avg. Volume
620,590.74
EPS (Annual)
-$0.6998
P/B
17.55
Rev/Employee
$272,956.52
$399.15
Loading...
Loading...
News
all
press releases
ClearPoint Neuro (CLPT) to Release Earnings on Wednesday
ClearPoint Neuro (NASDAQ:CLPT) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...
MarketBeat·13d ago
News Placeholder
More News
News Placeholder
CLPT Gets EU MDR Certification for ClearPoint Navigation Software
ClearPoint secures EU MDR certification for ClearPoint Navigation Software 3.0.2, expanding precision-guided surgery access across MRI suites and operating rooms.
Zacks·1mo ago
News Placeholder
Geode Capital Management LLC Buys 323,429 Shares of ClearPoint Neuro, Inc. $CLPT
Geode Capital Management LLC increased its position in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 107.3% in the second quarter, according to its most recent disclosure with the Securities...
MarketBeat·3mo ago
News Placeholder
ClearPoint Neuro (NASDAQ:CLPT) Cut to Sell at Wall Street Zen
Wall Street Zen cut ClearPoint Neuro from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·4mo ago
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.00% and -10.50%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +25.00% and -3.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Integra LifeSciences (IART) Q3 Earnings Beat Estimates
Integra (IART) delivered earnings and revenue surprises of +25.58% and -3.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
TransMedics (TMDX) Beats Q3 Earnings Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of +78.38% and -0.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
Zacks·5mo ago
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.00% and -3.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7mo ago
<
1
2
...
>

Latest CLPT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.